Research Areas
Herbal Medicine
Good Traditional Chinese Medicine Comes from Meticulous Decoction
01. Extreme Cell-Wall Disruption & Release Technology
Core Processes:High-pressure steam explosion cell-wall breaking
Plant fiber cell walls are fully shattered, enabling rapid and sufficient extraction of active substances
Core Processes:Bio-enzymatic hydrolysis
Extreme cell-wall disruption ensures fast dissolution and release of active ingredients
Electron microscopy image of the steam-explosion & enzymatic compound wall-breaking process
Electron microscopy image of normal plant cell structure
02. Rotary Cutting & Slow Decoction Technology
Core Processes:High-speed rotary cutting technology
Rapid and high-yield release of active components
Core Processes:Slow simmering under controlled heat
Active ingredients are thoroughly liberated and integrated
SEM image of herbal materials under conventional extraction
SEM image of herbal materials under rotary cutting & slow decoction
03. Triple-Stage Composite Physical Impurity-Removal Technology
Core Processes:Disc centrifugation filtration; membrane filtration
Core Processes:Adsorption and clarification impurity-removal technology
Loss of active ingredients is reduced by more than 30% compared with traditional processes；High active-substance retention; no pipeline blockage; long-term stability (R.S.)
Content level under conventional impurity removal before purification
Content level under effective physical impurity-removal process (R.S.)
04. Fluidized Instant Drying Technology
Core Processes:Low-temperature fluidized-bed drying and granulation
High drug loading, excellent homogeneity, rapid dissolution, no white spots
Core Processes:Fluidized instant drying technology
Minimal loss of heat-sensitive components; superior flowability, looseness, and solubility of finished products
Western Medicine
Raw Material Quality
Comparable to international standards
Raw Material Application
Proprietary purification technology
Raw Material Formulation
Integration of advanced technologies
Premium Excipients
Bioactive excipient technologies
High-Standard Production & Quality Control
Production:Independent production lines dedicated to group products; advanced integrated production equipment
Quality Control:Independent and comprehensive product quality management system; rigorous and high-standard quality monitoring requirements
Scientific Clinical Validation System
The only company in China’s veterinary pharmaceutical industry implementing a Phase III clinical validation model, ensuring high-quality clinical performance of all marketed products.
Technological Achievements
● Supramolecular inclusion technology: Enhances water solubility of poorly soluble drugs.
● Nano-emulsion technology: Enables faster onset and stronger efficacy.
● New coating technology: Masks bitterness and improves palatability.
● Crystal form modulation technology: Increases drug potency.
● Colloidal thixotropy technology: Ensures smoother suspension and improved syringeability.
● Sustained and controlled release technology: Enhances safety and prolongs therapeutic effect.
Microecologics
Equipped with a core R&D team mastering internationally advanced technologies, the platform integrates strain screening, isolation and preservation; liquid fermentation; solid-state fermentation; purification of active metabolites; and microecological formulation technologies. It possesses full-chain innovation capability from fundamental microecological research to prototype development, and from bench-scale and pilot-scale trials to large-scale industrial production.
World-Class Technologies
● World-class upstream microbial fermentation and downstream separation–purification technologies.
● World-class R&D and large-scale production technologies for novel microbial formulations.
● World-class R&D and modern manufacturing technologies for microecological metabolites.
● World-class technologies for developing microbial feed additives.
● Internationally leading R&D and industrialization capabilities for antimicrobial peptides targeting superbugs.
In-Depth Livestock & Poultry Analysis
● Metagenomic-level analysis to identify potential pathogenic bacteria.
● Extensive strain resources: functional and stress-resistant strains (enzyme-producing, antibacterial).
● Precision solutions: customized fermentation-based targeted products.
● Strong scientific research support enabling continuous development of new products.
Field of Additives
Functional additives are health-oriented solutions designed to address the mismatch between the pursuit of high production performance in livestock farming and the limitations of feeding management, breeding science, and feed science.
The company has been deeply engaged in the field of functional additives for more than ten years, establishing traditional Chinese herbal feed additives as its core R&D direction. All formulations are designed scientifically based on the real conditions of livestock and poultry production, ensuring reliable clinical outcomes. High-quality raw materials are carefully selected to guarantee product stability and efficacy. By continuously monitoring changes in mainstream farming practices across China, the company adjusts its core formulations in real time to meet practical production needs and deliver cost-effective solutions.
The company has built a high-standard workshop for mixed feed additives, applied for competitive feed additive licenses, and integrated its leading technological advantages. It actively seeks cooperation with advanced enterprises in the industry to further strengthen its technical leadership in the functional additive sector.
Field of Biological Products for Poultry
Qixiang Bio, as a poultry vaccine enterprise with strong social responsibility, is committed to the supply of high-quality vaccines and the development of innovative vaccine products. It was among the first in the industry to pass the new Veterinary Drug GMP certification. The company invested heavily in the construction of high-standard continuous production facilities and online quality assurance systems, significantly improving the efficacy, consistency, and clinical performance of poultry vaccines. The vaccines developed by Qixiang Bio help enhance disease resistance and promote healthy development in the poultry industry.
Qixiang Bio's vaccine products feature reduced immunization frequency, smaller injection volumes, and lower stress responses. These advantages reduce the number of vaccinations required for poultry, increase vaccination efficiency, and lower transportation, storage, and administration costs. The “multi-protection with one injection” concept effectively reduces the burden on farmers and contributes to cost reduction and efficiency improvement.
Genetic engineering and cell-suspension culture technologies—characterized by scalability, large batch sizes, uniformity, and high safety—are well suited for advanced vaccine manufacturing. Qixiang Bio incorporates these cutting-edge technologies during product development, significantly enhancing vaccine quality indicators. The resulting vaccines feature high potency, low stress, and broad-spectrum protection, and are widely welcomed and recognized by farmers.
Qixiang Bio places great emphasis on technological innovation and R&D as engines of enterprise development. It has established strategic alliances with more than twenty scientific research institutions, including the China Animal Health and Epidemiology Center, China Agricultural University, Henan Agricultural University, Guangxi University, South China Agricultural University, and Fujian Academy of Agricultural Sciences.
Led by Professor Zhang Gaiping—a member of the Chinese Academy of Engineering and Chief Scientist of Qixiang Bio—the Henan Longxiang Modern Immunology Laboratory focuses on "super vaccines" characterized by trace dosages, high precision, and superior safety, aimed at addressing the needs of human and animal health and biopharmaceutical industries. In recent years, Qixiang Bio and the research team led by Academician Zhang have made steady progress, with collaborative vaccine projects conducted with Longhu Laboratory achieving phased breakthroughs. In the coming stage, the “super vaccines” developed by Qixiang Bio are expected to bring transformative technological innovation and disruptive breakthroughs to the industry.
The company’s production and R&D teams uphold craftsmanship, innovation, and continuous improvement, resulting in numerous patented technologies and industry-first achievements:
◆ First to achieve large-scale production of inactivated vaccines
◆ First to adopt fully automated egg-harvesting systems
◆ First to implement antigen purification and concentration technology
◆ First to use continuous-flow centrifugation and ultrafiltration concentration systems
◆ First to utilize fully automated vaccine inactivation systems
◆ First to adopt high-shear emulsification systems
Contact Us
WhatsApp：+86-13783716883
Tel:+86-371-86585166
Mobile: +86-13783716883
E-mail: muxiangyaoye@muxiang.cn
Address: NO.9 Yugang Road Xinzheng Comprehensive Bonded Zone, Zhengzhou, P.R.China.
